Is Third Harmonic Stock a Good Investment?
Third Harmonic Investment Advice | THRD |
- Examine Third Harmonic's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Third Harmonic's leadership team and their track record. Good management can help Third Harmonic navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Third Harmonic's business and its evolving consumer preferences.
- Compare Third Harmonic's performance and market position to its competitors. Analyze how Third Harmonic is positioned in terms of product offerings, innovation, and market share.
- Check if Third Harmonic pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Third Harmonic's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Third Harmonic Bio stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Third Harmonic Bio is a good investment.
Sell | Buy |
Sell
Market Performance | OK | Details | |
Volatility | Relatively risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Third Harmonic Stock
Researching Third Harmonic's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 92.0% of the company shares are owned by institutional investors. The book value of Third Harmonic was at this time reported as 6.59. The company recorded a loss per share of 0.82. Third Harmonic Bio last dividend was issued on the August 6, 2014. The entity had 105:100 split on the February 11, 2011.
To determine if Third Harmonic is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Third Harmonic's research are outlined below:
| Third Harmonic Bio had very high historical volatility over the last 90 days | |
| Net Loss for the year was (30.82 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Third Harmonic Bio currently holds about 112.73 M in cash with (20.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 25.53, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Third Harmonic Bio has a frail financial position based on the latest SEC disclosures | |
| Over 92.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Third Harmonic Bio to Participate in Upcoming Investor Conferences in November |
Third Harmonic Quarterly Cash And Short Term Investments |
|
Third Harmonic uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Third Harmonic Bio. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Third Harmonic's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 3rd of April 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 3rd of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Third Harmonic's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Third Harmonic's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-09-30 | 2024-09-30 | -0.3 | -0.33 | -0.03 | 10 | ||
2023-11-09 | 2023-09-30 | -0.27 | -0.19 | 0.08 | 29 | ||
2024-05-15 | 2024-03-31 | -0.31 | -0.2 | 0.11 | 35 | ||
2023-03-29 | 2022-12-31 | -0.47 | -0.36 | 0.11 | 23 | ||
2024-03-26 | 2023-12-31 | -0.31 | -0.17 | 0.14 | 45 | ||
2022-11-09 | 2022-09-30 | -0.41 | -0.69 | -0.28 | 68 | ||
2023-05-11 | 2023-03-31 | -0.35 | -0.81 | -0.46 | 131 | ||
2023-08-10 | 2023-06-30 | -0.3 | 0.19 | 0.49 | 163 |
Know Third Harmonic's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Third Harmonic is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Third Harmonic Bio backward and forwards among themselves. Third Harmonic's institutional investor refers to the entity that pools money to purchase Third Harmonic's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Geode Capital Management, Llc | 2024-06-30 | 432.5 K | State Street Corp | 2024-06-30 | 385.9 K | Schonfeld Strategic Advisors Llc | 2024-06-30 | 330.2 K | Amvescap Plc. | 2024-06-30 | 271 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 255.4 K | Sio Capital Management, Llc | 2024-06-30 | 163.4 K | Northern Trust Corp | 2024-06-30 | 152 K | Charles Schwab Investment Management Inc | 2024-06-30 | 137.5 K | Parkman Healthcare Partners Llc | 2024-06-30 | 133.3 K | Orbimed Advisors, Llc | 2024-06-30 | 5.8 M | Bvf Inc | 2024-06-30 | 4.4 M |
Third Harmonic's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 675.88 M.Market Cap |
|
Third Harmonic's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.11) | (0.12) | |
| Return On Capital Employed | (0.16) | (0.17) | |
| Return On Assets | (0.11) | (0.12) | |
| Return On Equity | (0.11) | (0.11) |
Determining Third Harmonic's profitability involves analyzing its financial statements and using various financial metrics to determine if Third Harmonic is a good buy. For example, gross profit margin measures Third Harmonic's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Third Harmonic's profitability and make more informed investment decisions.
Please note, the presentation of Third Harmonic's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Third Harmonic's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Third Harmonic's management manipulating its earnings.
Evaluate Third Harmonic's management efficiency
Third Harmonic Bio has return on total asset (ROA) of (0.1126) % which means that it has lost $0.1126 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1381) %, meaning that it created substantial loss on money invested by shareholders. Third Harmonic's management efficiency ratios could be used to measure how well Third Harmonic manages its routine affairs as well as how well it operates its assets and liabilities. As of November 11, 2024, Return On Tangible Assets is expected to decline to -0.12. In addition to that, Return On Capital Employed is expected to decline to -0.17. The current year's Debt To Assets is expected to grow to 0.02, whereas Total Assets are forecasted to decline to about 196.3 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 6.79 | 7.13 | |
| Tangible Book Value Per Share | 6.79 | 7.13 | |
| Enterprise Value Over EBITDA | (3.87) | (4.06) | |
| Price Book Value Ratio | 1.62 | 1.70 | |
| Enterprise Value Multiple | (3.87) | (4.06) | |
| Price Fair Value | 1.62 | 1.70 | |
| Enterprise Value | -103.7 M | -108.9 M |
The strategic initiatives led by Third Harmonic's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Beta 2.861 |
Basic technical analysis of Third Stock
As of the 11th of November 2024, Third Harmonic has the Risk Adjusted Performance of 0.1089, semi deviation of 4.22, and Coefficient Of Variation of 754.16. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Third Harmonic Bio, as well as the relationship between them. Please validate Third Harmonic Bio jensen alpha, as well as the relationship between the potential upside and skewness to decide if Third Harmonic is priced more or less accurately, providing market reflects its prevalent price of 15.0 per share. Given that Third Harmonic Bio has jensen alpha of 0.1803, we advise you to double-check Third Harmonic Bio's current market performance to make sure the company can sustain itself at a future point.Third Harmonic's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Third Harmonic insiders, such as employees or executives, is commonly permitted as long as it does not rely on Third Harmonic's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Third Harmonic insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Third Harmonic's Outstanding Corporate Bonds
Third Harmonic issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Third Harmonic Bio uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Third bonds can be classified according to their maturity, which is the date when Third Harmonic Bio has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Understand Third Harmonic's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Third Harmonic's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1089 | |||
| Market Risk Adjusted Performance | 0.2398 | |||
| Mean Deviation | 3.26 | |||
| Semi Deviation | 4.22 | |||
| Downside Deviation | 4.53 | |||
| Coefficient Of Variation | 754.16 | |||
| Standard Deviation | 4.43 | |||
| Variance | 19.66 | |||
| Information Ratio | 0.0947 | |||
| Jensen Alpha | 0.1803 | |||
| Total Risk Alpha | (0.35) | |||
| Sortino Ratio | 0.0926 | |||
| Treynor Ratio | 0.2298 | |||
| Maximum Drawdown | 27.09 | |||
| Value At Risk | (4.34) | |||
| Potential Upside | 9.11 | |||
| Downside Variance | 20.56 | |||
| Semi Variance | 17.84 | |||
| Expected Short fall | (3.41) | |||
| Skewness | (0.26) | |||
| Kurtosis | 2.16 |
| Risk Adjusted Performance | 0.1089 | |||
| Market Risk Adjusted Performance | 0.2398 | |||
| Mean Deviation | 3.26 | |||
| Semi Deviation | 4.22 | |||
| Downside Deviation | 4.53 | |||
| Coefficient Of Variation | 754.16 | |||
| Standard Deviation | 4.43 | |||
| Variance | 19.66 | |||
| Information Ratio | 0.0947 | |||
| Jensen Alpha | 0.1803 | |||
| Total Risk Alpha | (0.35) | |||
| Sortino Ratio | 0.0926 | |||
| Treynor Ratio | 0.2298 | |||
| Maximum Drawdown | 27.09 | |||
| Value At Risk | (4.34) | |||
| Potential Upside | 9.11 | |||
| Downside Variance | 20.56 | |||
| Semi Variance | 17.84 | |||
| Expected Short fall | (3.41) | |||
| Skewness | (0.26) | |||
| Kurtosis | 2.16 |
Consider Third Harmonic's intraday indicators
Third Harmonic intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Third Harmonic stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Third Harmonic Corporate Filings
10Q | 7th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
F4 | 5th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 27th of September 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
8K | 7th of June 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Third Stock media impact
Far too much social signal, news, headlines, and media speculation about Third Harmonic that are available to investors today. That information is available publicly through Third media outlets and privately through word of mouth or via Third internal channels. However, regardless of the origin, that massive amount of Third data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Third Harmonic news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Third Harmonic relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Third Harmonic's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Third Harmonic alpha.
Third Harmonic Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Third Harmonic can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Third Harmonic Corporate Management
| Robert Ho | Chief Officer | Profile | |
| Christopher Dinsmore | Chief Officer | Profile | |
| Dennis Dean | Chief Officer | Profile | |
| Gregg Keaney | VP Devel | Profile | |
| Christopher Murphy | Chief Officer | Profile | |
| Adrian Ray | Chief Officer | Profile | |
| Ommer Chohan | Treasurer Secretary | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Third Harmonic Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Third Harmonic. If investors know Third will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Third Harmonic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.82) | Return On Assets (0.11) | Return On Equity (0.14) |
The market value of Third Harmonic Bio is measured differently than its book value, which is the value of Third that is recorded on the company's balance sheet. Investors also form their own opinion of Third Harmonic's value that differs from its market value or its book value, called intrinsic value, which is Third Harmonic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Third Harmonic's market value can be influenced by many factors that don't directly affect Third Harmonic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Third Harmonic's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Third Harmonic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Third Harmonic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.